3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Basal Cell
5
Multiple Myeloma
3
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Lymphoma
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Platinum-Resistant Fallopian Tube Carcinoma
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Unknown Primary
1
Neoplasms, Basal Cell
1
Neoplasms
1
Meningioma
1
Melanoma
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Infratentorial Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Interventions
Cyclophosphamide
12
Specimen Handling
9
cabozantinib
8
X-Rays
8
Magnetic Resonance Spectroscopy
8
fludarabine
7
Phantoms, Imaging
7
Biopsy
7
Temozolomide
6
Gemcitabine
5
regorafenib
4
pembrolizumab
4
Vincristine
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Methotrexate
4
Doxorubicin
4
olaparib
3
irinotecan sucrosofate
3
fludarabine phosphate
3
dinutuximab
3
Zoledronic Acid
3
Surveys and Questionnaires
3
Irinotecan
3
Ifosfamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Osteosarcoma
×
HhAntag691
×
1 year
×
Clear all
No trials found.